Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 116937
Published online Aug 15, 2026. doi: 10.4251/wjgo.116937
Published online Aug 15, 2026. doi: 10.4251/wjgo.116937
Figure 5 TCHP knockdown suppresses gastric cancer cell growth in vivo.
A: Tumor volumes in mouse xenograft models were compared between negative control (NC) and shTCHP3 groups; B: Tumor growth curves showed the tumor volumes measured every seven days; C: Final tumor weights were significantly lower in the shTCHP3 group compared to the NC group; D: Representative images of H&E staining of tumor tissues; E: Western blotting confirmed the knockdown of TCHP in the harvested tumors; F: The expression of Ki67 protein was detected by immunohistochemistry; G: Apoptosis in the subcutaneous xenograft model was assessed by the TUNEL assay. Data are presented as mean ± SD; n = 4 mice per group. aP < 0.05; bP < 0.01; cP < 0.001. NC: Negative control.
- Citation: Wang Y, Zhang TY, Shen YF, Shen N, Zhang ZW. TCHP regulates the proliferation and apoptosis of gastric cancer cells via AKT/BCL2 signaling pathway. World J Gastrointest Oncol 2026; 18(8): 116937
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/116937.htm
- DOI: https://dx.doi.org/10.4251/wjgo.116937